The DYRK family of kinases in cancer: molecular functions and therapeutic opportunities

J Boni, C Rubio-Perez, N López-Bigas, C Fillat… - Cancers, 2020 - mdpi.com
DYRK (dual-specificity tyrosine-regulated kinases) are an evolutionary conserved family of
protein kinases with members from yeast to humans. In humans, DYRKs are pleiotropic …

Non-kinase targets of protein kinase inhibitors

L Munoz - Nature Reviews Drug Discovery, 2017 - nature.com
Kinome-wide profiling platforms have comprehensively identified the relevant kinases that
are targeted by numerous protein kinase inhibitors. However, recent projects have begun to …

One Stone, Two Birds: High-Brightness Aggregation-Induced Emission Photosensitizers for Super-Resolution Imaging and Photodynamic Therapy

Z Wang, Y Zhou, Y Hao, Z Zhao, A Gao, H Ma… - Nano Letters, 2024 - ACS Publications
Most aggregation-induced emission (AIE) luminogens exhibit high brightness, excellent
photostability, and good biocompatibility, but these AIE-active agents, which kill two birds …

Novel natural product-and privileged scaffold-based tubulin inhibitors targeting the colchicine binding site

M Dong, F Liu, H Zhou, S Zhai, B Yan - Molecules, 2016 - mdpi.com
Tubulin inhibitors are effective anticancer agents, however, there are many limitations to the
use of available tubulin inhibitors in the clinic, such as multidrug resistance, severe side …

Structural optimization and pharmacological evaluation of inhibitors targeting dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) and CDC-like …

Q Zhou, AF Phoa, RH Abbassi, M Hoque… - Journal of Medicinal …, 2017 - ACS Publications
The DYRK family contains kinases that are up-regulated in malignancy and control several
cancer hallmarks. To assess the anticancer potential of inhibitors targeting DYRK kinases …

Synthesis, biological evaluation of novel thiopyrano [2, 3-d] thiazoles incorporating arylsulfonate moiety as potential inhibitors of tubulin polymerization, and molecular …

NH Metwally, MA Badawy, DS Okpy - Journal of Molecular Structure, 2022 - Elsevier
Abstract Novel series of thiopyrano [2, 3-d] 1, 3-thiazole derivatives incorporating
arylsulfonate moiety were synthesized and characterized by 1 H NMR, 13 C NMR, MS, and …

Microtubule depolymerization by kinase inhibitors: unexpected findings of dual inhibitors

K Tanabe - International Journal of Molecular Sciences, 2017 - mdpi.com
Microtubule-targeting agents are widely used as clinical drugs in the treatment of cancer.
However, some kinase inhibitors can also disrupt microtubule organization by directly …

Multi-targeting anticancer agents: Rational approaches, synthetic routes and structure activity relationship

H Singh, N Kinarivala, S Sharma - Anti-Cancer Agents in …, 2019 - ingentaconnect.com
We live in a world with complex diseases such as cancer which cannot be cured with one-
compound one-target based therapeutic paradigm. This could be due to the involvement of …

Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis

S Masaki, I Kii, Y Sumida, T Kato-Sumida… - Bioorganic & Medicinal …, 2015 - Elsevier
Dysregulation of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A)
has been demonstrated in several pathological conditions, including Alzheimer's disease …

DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing

NT Issa, J Kruger, H Wathieu, R Raja, SW Byers… - BMC …, 2016 - Springer
Background The targeting of disease-related proteins is important for drug discovery, and
yet target-based discovery has not been fruitful. Contextualizing overall biological processes …